Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2014 / Jun / Killer Apps and Game-Changers
Business and Entrepreneurship Health Economics and Policy

Killer Apps and Game-Changers

At last, a unique and useful function for femtosecond laser systems has emerged. Meantime, big data is set to totally transform our practice of medicine. Changes small and large keep ophthalmology alive!

By Mark Hillen 6/17/2014 1 min read

Share

Unnecessary gadget. Expensive toy. Purely a marketing tool for your practice. These are a few of the phrases that I’ve heard used to describe femtosecond lasers, coined because there’s no evidence that femtosecond lasers achieve better optical outcomes than manual surgery. But I think there’s a general feeling that the age of femtosecond lasers is inevitable. Costs will fall, the capabilities will improve, the process will become faster, and eventually, post-surgical optical outcomes will be better than by hand. But that hasn’t happened so far so many surgeons feel that there’s no truly compelling reason to buy one… yet.

Perhaps what the femtosecond laser market needs is its  own VisiCalc. Let me explain. In the 1980s, microcomputers were expensive toys – cool, not that useful, but somehow the future. Before the IBM PC, the Apple II was the dominant computer. In 1980 it cost US$2000 (US$5,750 in today’s money), and initially, sales were low. Then VisiCalc, the first spreadsheet available on a microcomputer appeared. People instantly saw how useful it was. They needed it. And it was only available on the Apple II. This “killer app” made Apple II sales skyrocket – and was the making of Apple. We await that first femtosecond laser killer app. I wonder if Laser Bridge astigmatic keratotomy ("Is this Femto’s Killer App?") is it. So far, its utility has been demonstrated only in computer simulations, but it exploits everything that a femtosecond laser has to offer – variable incision depth and ablation widths – capabilities that the human hand would struggle to (or cannot) achieve.

Spreadsheets are no longer a killer app. Their introduction did transform our ability to perform data analyses, but crucially, only if the data was entered in the right way. Natural language information analysis is the next data analysis frontier; it means that you could throw any old document at a big data analytics machine and get a cogent analysis in return. Not so much a killer app, as a game-changer: just imagine what it could do with written medical records! Pete Sudbury, a UK-based NHS consultant who’s currently on secondment at HP’s Enterprise Services division, has a unique perspective on what big data can do for medicine and ophthalmology. He shares his view of the future in "Big Data". Now, when do I get my flying car?

About the Author(s)

Mark Hillen

I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.

More Articles by Mark Hillen

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: